Advertisement
PerkinElmer
PerkinElmer

The Scientist

» industry, microbiology and immunology

Most Recent

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: Brrrr-ying the Results

Brrrr-ying the Results

By | July 1, 2015

Holding laboratory mice at temperatures lower than those the animals prefer could be altering their physiology and skewing experimental results.

0 Comments

image: Sold on Symbiosis

Sold on Symbiosis

By | July 1, 2015

A love of the ocean lured Nicole Dubilier into science; gutless sea worms and their nurturing bacterial symbionts keep her at the leading edge of marine microbiology.

0 Comments

image: Sponging Up Phosphorus

Sponging Up Phosphorus

By | July 1, 2015

Symbiotic bacteria in Caribbean reef sponges store polyphosphate granules, possibly explaining why phosphorous is so scarce in coral reef ecosystems.

0 Comments

image: You Gutless Worm

You Gutless Worm

By | July 1, 2015

Meet the digestive tract-lacking oligochaete that has fueled Max Planck research Nicole Dubilier's interest in symbiosis and marine science.

0 Comments

image: The Sum of Our Parts

The Sum of Our Parts

By , and | July 1, 2015

Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

2 Comments

image: Diagnosing Ebola in 15 Minutes

Diagnosing Ebola in 15 Minutes

By | June 30, 2015

A new test that scans for the Ebola virus with just a fingerprick could be a practical diagnostic for use in West Africa.

0 Comments

image: Sex Differences in Pain Pathway

Sex Differences in Pain Pathway

By | June 29, 2015

Male and female mice utilize different immune cells to process pain, a study shows.

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

image: Neutralizing HIV

Neutralizing HIV

By | June 18, 2015

Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.

0 Comments

Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Neanderthal-Human Hybrid Unearthed
  3. Sex Differences in Pain Pathway
  4. Antibiotics and the Gut Microbiome
Advertisement
BioLegend
BioLegend
Advertisement
The Scientist